Literature DB >> 24444317

The role of cognition in outcome in schizophrenia and related disorders.

Ashok Malla1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24444317      PMCID： PMC4079227          DOI： 10.1177/070674371405900102

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  7 in total

1.  The personal meaning of recovery among individuals treated for a first episode of psychosis.

Authors:  Deborah Windell; Ross Norman; Ashok K Malla
Journal:  Psychiatr Serv       Date:  2012-06       Impact factor: 3.084

2.  Recovery: a dimensional approach.

Authors:  Rob Whitley; Robert E Drake
Journal:  Psychiatr Serv       Date:  2010-12       Impact factor: 3.084

3.  Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

Authors:  Clifford M Cassidy; Ross Norman; Rahul Manchanda; Norbert Schmitz; Ashok Malla
Journal:  Schizophr Bull       Date:  2009-03-25       Impact factor: 9.306

Review 4.  Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies.

Authors:  Tarek K Rajji; Dielle Miranda; Benoit H Mulsant
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

Review 5.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

Review 6.  Remission in schizophrenia: proposed criteria and rationale for consensus.

Authors:  Nancy C Andreasen; William T Carpenter; John M Kane; Robert A Lasser; Stephen R Marder; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

Review 7.  Neurocognition in first-episode schizophrenia: a meta-analytic review.

Authors:  Raquelle I Mesholam-Gately; Anthony J Giuliano; Kirsten P Goff; Stephen V Faraone; Larry J Seidman
Journal:  Neuropsychology       Date:  2009-05       Impact factor: 3.295
  7 in total
  1 in total

1.  FOXP2 contributes to the cognitive impairment in chronic patients with schizophrenia.

Authors:  Xiaoe Lang; Wenzhong Zhang; Xinxin Song; Guangya Zhang; Xiangdong Du; Yongjie Zhou; Zezhi Li; Xiang Yang Zhang
Journal:  Aging (Albany NY)       Date:  2019-08-19       Impact factor: 5.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.